COMPARE
Franklin India Opportunities Fund - Direct - Growth vs ITI Pharma and Healthcare Fund - Direct Plan - Growth Option
Franklin India Opportunities Fund and ITI Pharma and Healthcare Fund are both in the Sectoral/ Thematic category, from Franklin Templeton Asset Management (India) Private Limited and ITI Asset Management Limited respectively. ITI Pharma and Healthcare Fund has posted a higher 3-year rolling CAGR. Franklin India Opportunities Fund has the lower expense ratio. See the full table and FAQ below for the complete real-data comparison.
Basics
Franklin India Opportunities Fund has the lower direct-plan expense ratio, by 0.04 percentage points.
| Franklin India Opportunities Fund - Direct - Growth | ITI Pharma and Healthcare Fund - Direct Plan - Growth Option | |
|---|---|---|
| Category | Sectoral/ Thematic | Sectoral/ Thematic |
| AMC | Franklin Templeton Asset Management (India) Private Limited | ITI Asset Management Limited |
| Benchmark | Nifty 500 TRI | Nifty Healthcare Index TRI |
| NAV | ₹276.9738 (2026-10-28) | ₹19.2196 (2026-10-28) |
| AUM | ₹9,055.35 Cr | ₹253.15 Cr |
| Expense Ratio (Direct) | 0.88% | 0.92% |
| Inception | 2000-02-21 | 2021-10-18 |
Returns
ITI Pharma and Healthcare Fund leads on 3-year rolling CAGR (21.5% vs Franklin India Opportunities Fund's 19.1%) - see the FAQ below for percentile context within each fund's own category.
Risk Metrics
Franklin India Opportunities Fund has been the more volatile of the two by standard deviation.
| Franklin India Opportunities Fund - Direct - Growth | ITI Pharma and Healthcare Fund - Direct Plan - Growth Option | |
|---|---|---|
| 3Y Sharpe Ratio | 0.57 | 0.62 |
| 3Y Alpha | 7.869% | -0.0766% |
| 3Y Std Deviation | 15.902% | 15.1879% |
| 3Y Calmar Ratio | 0.90 | 0.96 |
Portfolio Analytics
ITI Pharma and Healthcare Fund carries the higher portfolio P/E ratio (a rougher proxy for how richly the underlying holdings are valued) - see the table below for the full comparison.
| Franklin India Opportunities Fund - Direct - Growth | ITI Pharma and Healthcare Fund - Direct Plan - Growth Option | |
|---|---|---|
| P/E Ratio | 32.3127 | 47.6644 |
| P/B Ratio | - | 10.04 |
| Dividend Yield | 0.5729% | 0.4332% |
| Active Share | 84.75% | 29.85% |
| Portfolio Turnover | 73.50999999999999% | 53% |
| YTM | 5.3428% | - |
| Duration (Macaulay) | - | - |
Punji Fund Health Score
Franklin India Opportunities Fund has the stronger Punji Quality grade of the two.
Frequently asked questions
Which has a higher 3-year return, Franklin India Opportunities Fund or ITI Pharma and Healthcare Fund?
ITI Pharma and Healthcare Fund's 3-year rolling CAGR of 21.5% is higher than Franklin India Opportunities Fund's 19.1%. ITI Pharma and Healthcare Fund sits in the 84th percentile of its category on this metric, versus the 70th percentile for Franklin India Opportunities Fund - though note both funds may belong to different categories with different medians, so a raw CAGR comparison doesn't account for how each fund performed relative to its own peers. A higher historical return also doesn't necessarily mean lower risk; check the risk metrics below before concluding either fund is the "better" choice.
Which has a lower expense ratio, Franklin India Opportunities Fund or ITI Pharma and Healthcare Fund?
Franklin India Opportunities Fund's direct-plan expense ratio is 0.04 percentage points lower than ITI Pharma and Healthcare Fund's. Over long holding periods, a persistent expense-ratio gap compounds into a materially different final corpus even if the two funds' gross returns are similar - it's one of the few fund attributes you can compare with total certainty upfront, unlike future returns, since the fee is contractually fixed rather than a historical estimate.
Which fund carries more risk, Franklin India Opportunities Fund or ITI Pharma and Healthcare Fund?
By standard deviation (a measure of how much a fund's returns swing around its own average), Franklin India Opportunities Fund has been more volatile than ITI Pharma and Healthcare Fund over the trailing window. Standard deviation captures total volatility in both directions - up and down - so a higher figure means bigger swings generally, not necessarily bigger losses specifically. Sharpe ratio (0.57 for Franklin India Opportunities Fund vs 0.62 for ITI Pharma and Healthcare Fund) is a better single measure of risk-adjusted return, since it weighs the return earned per unit of volatility taken rather than volatility alone.
Which has higher AUM, Franklin India Opportunities Fund or ITI Pharma and Healthcare Fund?
Franklin India Opportunities Fund has ₹9,055 Cr in assets under management, versus ₹253 Cr for ITI Pharma and Healthcare Fund. A larger AUM generally means deeper liquidity and lower per-unit fixed costs for the AMC to spread across investors, but an AUM that's very large relative to a fund's category and strategy (especially in small/mid cap categories, where the investable universe is smaller) can also make it harder for a manager to enter and exit positions without moving the price - bigger isn't automatically better, especially for less liquid categories.
Which fund has a longer track record, Franklin India Opportunities Fund or ITI Pharma and Healthcare Fund?
Franklin India Opportunities Fund launched on 2000-02-21, making it older than ITI Pharma and Healthcare Fund (launched 2021-10-18). A longer track record means more real market cycles (bull runs, corrections, rate cycles) the fund has actually navigated, which is useful context for judging consistency - but it isn't a guarantee of future performance, and a newer fund isn't automatically worse, especially if it's run by an experienced manager or team with a track record at a prior fund.
Data as of 2026-10-29. Source: AMFI disclosures via Punji. Not investment advice.